References
- Graziano J H. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1986; 1: 155–162
- Fournier L, Thomas G, Garnier R, et al. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med Toxicol Adverse Drug Exp 1988; 3: 499–504
- Cory-Slechta D A. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Pharmacol Exp Ther 1988; 246: 84–91
- Aposhian H V, Aposhian M M. Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 1990; 30: 279–306
- Nightingale S L. Succimer (DMSA) approved for severe lead poisoning. JAMA 1991; 265: 1802
- Friedheim E, Graziano J H, Popovac D, et al. Treatment of lead poisoning by 2,3-dimercaptosuccinic acid. Lancet 1978; 2: 1234–1236
- Emmerson B T. Chronic lead nephropathy: the diagnostic use of calcium EDTA and the association with gout. Australas Ann Med 1963; 12: 310–324
- Dhawan M, Flora S J, Singh S, Tandon S K. Chelation of lead during co-exposure to ethanol. Biochem Intern 1989; 19: 1067–1075
- Valentine W N, Tanaka K R, Paglia D E. Hemolytic anemias and erythrocyte enzymopathies. Ann Intern Med 1985; 103: 245–257
- World Health Organization Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull WHO 1989; 67: 601–611
- Heller P, Best W R, Nelson R B, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001–1005
- Beutler E. Hemolytic anemia in disorders of red cell metabolism. Plenum Medical Book Co., New York 1978
- Hochstein P. Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. Free Radic Biol Med 1988; 5: 387–392
- Cullen M R, Robins J M, Eskenazi B. Adult inorganic lead intoxication: presentation of 31 new cases and a review of recent advances in the literature. Medicine-Baltimore 1983; 62: 221–247
- Grandjean P, Jensen B M, Sando S H, et al. Delayed blood regeneration in lead exposure: an effect on reverse capacity. Am J Public Health 1989; 79: 1385–1388
- Agency for Toxic Substances and Disease Registry. The Nature and Extent of Lead Poisoning in Children in the United States: A Report to Congress. ATSDR, Washington 1988
- Landrigan P J. Strategies for epidemiologic studies of lead in bone in occupationally exposed populations. Environ Health Perspect 1991; 91: 81–86
- Robinson J C. Trends in racial inequality and exposure to work-related hazards, 1968–1986. Milbank Q 1987; 65: 404–420, Suppl 2
- Friedman-Jimenez G. Occupational disease among minority workers: A common and preventable public health problem. AAOHN-J 1989; 37: 64–70, 84–86
- Eng K H. Assessment of occupational exposure to lead in a Malaysian battery factory. Proceedings of the Tenth Asian Conference on Occupational Health, Singapore, 1982, 481–486
- Matte T D, Figueroa J P, Burr G, et al. Lead exposure among lead-acid battery workers in Jamaica. Am J Ind Med 1989; 16: 167–177
- Gachamd M G, Ruiza F, Herrera A, et al. Preva-lencia de plomo corporal: correlacion clinica-epiderniologica en trabajadores de dos industrias y en sus contractos. Bol Itivestig 1976; 2: 10–24
- Graziano J H, Lolacono N J, Moulton T, et al. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 1992; 120: 133–139